|1.||Greenwood, Brian: 31 articles (12/2015 - 10/2005)|
|2.||Chandramohan, Daniel: 26 articles (12/2015 - 04/2003)|
|3.||Rosenthal, Philip J: 26 articles (08/2015 - 12/2002)|
|4.||Dorsey, Grant: 24 articles (07/2014 - 12/2002)|
|5.||Meshnick, Steven R: 18 articles (07/2014 - 06/2004)|
|6.||Mshinda, Hassan: 18 articles (03/2013 - 07/2002)|
|7.||D'Alessandro, Umberto: 17 articles (01/2015 - 06/2003)|
|8.||Roper, Cally: 16 articles (12/2015 - 04/2003)|
|9.||ter Kuile, Feiko O: 16 articles (06/2015 - 02/2003)|
|10.||Doumbo, Ogobara K: 16 articles (01/2015 - 07/2007)|
01/01/2011 - "The currently recommended approach for preventing malaria in pregnancy (MiP), intermittent preventive treatment with sulphadoxine-pyrimethamine (SP-IPT), has been questioned due to the spread of resistance to SP. Whilst trials are underway to test the efficacy of future alternative approaches, it is important to start exploring the feasibility of their implementation. "
01/01/2004 - "The object of this study is to assess the contribution in the field of two new antimalarial fight steps taken in 2001-2002: The use of the rapid diagnostic test (RDT) for malaria OptiMAL in the rural health centres and the drop of the CQ alone for the simultaneous administration of CQ and sulfadoxine-pyrimethamine (SP) as the first-line treatment for uncomplicated malaria. "
01/01/2015 - "Tanzania abandoned sulfadoxine-pyrimethamine (SP) as the first-line treatment for uncomplicated malaria in 2006 due to high levels Plasmodium falciparum resistance. "
01/01/2015 - "The efficacy of intermittent preventive treatment for malaria with sulfadoxine-pyrimethamine (IPTp-SP) in pregnancy is threatened in parts of Africa by the emergence and spread of resistance to SP. Intermittent screening with a rapid diagnostic test (RDT) and treatment of positive women (ISTp) is an alternative approach. "
12/01/2011 - "IPT in infants with sulphadoxine-pyrimethamine (SP) is cost effective in sites with high malaria transmission. "
|2.||Falciparum Malaria (Plasmodium falciparum Malaria)
03/06/2004 - "Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study."
09/01/2013 - "Therapeutic efficacy of sulfadoxine-pyrimethamine (SP), which is commonly used to treat falciparum malaria, was assessed in isolates of Plasmodium falciparum (Welch, 1897) and Plasmodium vivax (Grassi et Feletti, 1890) ofAligarh, Uttar Pradesh, North India and Taif, Saudi Arabia during 2011-2012. "
08/01/2010 - "The therapeutic efficacy of sulfadoxine-pyrimethamine (SP) in treating uncomplicated Plasmodium falciparum malaria is unevenly distributed in Colombia. "
08/01/2005 - "To assess the status of the therapeutic efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria to enable evidence based policy decisions. "
05/01/2005 - "Therapeutic efficacy of sulfadoxine-pyrimethamine for Plasmodium falciparum malaria."
01/01/2014 - "The secondary objectives are to determine the protective efficacy of CSST on maternal anaemia, maternal peripheral infection, low birth weight, selection of sulfadoxine-pyrimethamine (SP) resistance markers, and on antenatal clinic (ANC) attendance and coverage of intermittent preventive treatment during pregnancy (IPTp-SP). "
05/01/1972 - "Suppressive and curative trials in Plasmodium malariae infection with Fansidar."
01/01/2014 - "vivax bacteria is exposed to sulfadoxine-pyrimethamine due to misdiagnosis and mixed infections. "
01/01/2009 - "vivax infections are often exposed to sulphadoxine-pyrimethamine (SP). "
08/01/2007 - "Other predictors (in subgroups) were bed net use (OR = 0.49, 95% CI = 0.48-0.50); preventive sulfadoxine-pyrimethamine doses (OR = 0.25, 95% CI = 0.24-0.25); and infection with human immunodeficiency virus (HIV) (OR = 1.49, 95% CI = 1.11-2.00). "
01/01/2011 - "Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria."
01/01/2010 - "Compared to women without nets who did not receive 2-dose sulfadoxine-pyrimethamine, women using nets and receiving 2-dose sulfadoxine-pyrimethamine were less likely to have parasitemia or low birth weight babies. "
12/01/2006 - "Febrile adults with Plasmodium falciparum parasitemia were treated with sulfadoxine-pyrimethamine and were monitored for 28 days. "
09/15/2005 - "Parasitemia was defined as presence of asexual parasites on a thick film of blood and was treated with sulfadoxine/pyrimethamine (SP), in accordance with national policy. "
12/01/1981 - " In the Fansidar group, 4 of 22 patients took more than 15 days to clear the parasitemia. "
01/01/1988 - "-one cases were treated with sulfadoxine-pyrimethamine (1500 mg and 75 mg, respectively): 19 were cured, I showed RI and another had an S or RI response; the mean time for fever control was 56.1 hours.Fifty"
01/01/2013 - "In order to understand the effect of drug pressure on sulfadoxine-pyrimethamine (SP) resistance in pregnancy, a sample of pregnant women presenting with fever in out-patient clinics was studied. "
02/01/2012 - "In Tanzania CQ was stopped in 2001 but in Uganda CQ was retained in combination with sulfadoxine-pyrimethamine (SP) and used in home based management of fever for some time. "
01/01/2012 - "In 2006, individuals with history of fever within 24 hours or fever (axillary temperature ≥37.5°C) at presentation were presumptively treated using sulphadoxine/pyrimethamine. "
11/01/2006 - "In Uganda, a pre-packed fixed-dose combination of CQ plus sulfadoxine/pyrimethamine (CQ+SP) called Homapak is used in the home based management of fever program (HBM). "